Scolyer, Richard A., Atkinson, Victoria, Ch'ng, Sydney, Colebatch, Andrew J., Daneshvar, Dariush, Pires da Silva, Ines, Dawson, Tamara, Ferguson, Peter M., Foster-Smith, Erwin, Fox, Stephen B., Gill, Anthony J., Gupta, Ruta, Gyorki, David E., Henderson, MA, Hong, AM, Howle, JR, Jackett, LA, James, C, Lee, CS, Lochhead, A, Loh, D, McArthur, GA, McLean, CA, Lambie, Duncan, Menzies, AM, Nieweg, OE, O'Brien, BH, Pennington, TE, Potter, AJ, Prakash, S, Rawson, RV, Read, RL, Rtshiladze, MA, Shannon, KF, O'Toole, Sandra, Smithers, BM, Spillane, AJ, Stretch, JR, Thompson, JF, Tucker, P, Varey, AHR, Vilain, Ricardo E., Wood, BA, Long, GV, Saw, Robyn P. M., Amanuel, Benhur, Angel, Christopher M., Button-Sloan, Alison E., Carlino, Matteo S.. Elsevier; 2022. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting.